| Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02337426) | Virginia Commonwealth University | 2015-02-13 |
| Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas (NCT02186509) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-01-30 |
| 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (NCT02175745) | Erik Mittra | 2014-12-01 |
| Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma (NCT01977677) | Lawrence Recht | 2014-11-01 |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas (NCT02015819) | City of Hope Medical Center | 2014-10-07 |
| NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma (NCT01894061) | Case Comprehensive Cancer Center | 2013-09-18 |
| Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (NCT02194452) | Sue O'Dorisio | 2013-09-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma (NCT01730950) | Radiation Therapy Oncology Group | 2012-12-20 |
| Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01753713) | Manmeet Ahluwalia, MD | 2012-12-20 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01648348) | National Cancer Institute (NCI) | 2012-11-01 |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma (NCT01378481) | National Cancer Institute (NCI) | 2012-06-01 |
| 3T MRI Biomarkers of Glioma Treatment Response (NCT01996527) | Vanderbilt-Ingram Cancer Center | 2012-05-01 |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme (NCT01575275) | Michael Vogelbaum, MD, PhD | 2012-05-01 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases (NCT02967380) | University of Southern California | 2011-12-14 |
| Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas (NCT01478321) | Northwestern University | 2011-12-14 |
| RO4929097 in Treating Patients With Recurrent Invasive Gliomas (NCT01269411) | National Cancer Institute (NCI) | 2011-07-01 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT01189240) | National Cancer Institute (NCI) | 2010-12-01 |
| Yoga Therapy in Treating Patients With Malignant Brain Tumors (NCT01234805) | Wake Forest University Health Sciences | 2010-12-01 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases (NCT01234740) | City of Hope Medical Center | 2010-12-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01122901) | National Cancer Institute (NCI) | 2010-12-01 |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas (NCT01172964) | City of Hope Medical Center | 2010-08-01 |
| Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma (NCT01165632) | Mayo Clinic | 2010-07-26 |
| Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors (NCT01148966) | University of Washington | 2010-06-01 |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma (NCT01103375) | Wake Forest University Health Sciences | 2010-05-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT01119599) | National Cancer Institute (NCI) | 2010-05-01 |
| Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma (NCT00979862) | National Cancer Institute (NCI) | 2010-03-01 |
| GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery (NCT00980343) | National Cancer Institute (NCI) | 2010-02-01 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT01051557) | National Cancer Institute (NCI) | 2010-01-27 |
| Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme (NCT01122888) | National Cancer Institute (NCI) | 2009-12-01 |
| MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00902577) | National Cancer Institute (NCI) | 2009-08-24 |
| Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00731731) | National Cancer Institute (NCI) | 2009-07-10 |
| Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma (NCT00823797) | University of Washington | 2008-10-01 |
| Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma (NCT00650923) | National Cancer Institute (NCI) | 2008-07-01 |
| Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme (NCT00641706) | National Cancer Institute (NCI) | 2008-07-01 |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT00662506) | National Cancer Institute (NCI) | 2008-04-01 |
| Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00540722) | National Cancer Institute (NCI) | 2008-01-01 |
| Sunitinib in Treating Patients With Recurrent Malignant Gliomas (NCT00499473) | National Cancer Institute (NCI) | 2007-06-01 |
| Pazopanib in Treating Patients With Recurrent Glioblastoma (NCT00459381) | National Cancer Institute (NCI) | 2007-05-01 |
| Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma (NCT00423735) | National Cancer Institute (NCI) | 2007-01-24 |
| Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT00379080) | National Cancer Institute (NCI) | 2007-01-01 |
| Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00445588) | National Cancer Institute (NCI) | 2007-01-01 |
| VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide (NCT00369590) | National Cancer Institute (NCI) | 2006-08-01 |
| Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00316849) | National Cancer Institute (NCI) | 2006-05-01 |
| Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma (NCT00335764) | National Cancer Institute (NCI) | 2006-04-01 |
| Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT00305864) | National Cancer Institute (NCI) | 2006-02-09 |
| AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00305656) | National Cancer Institute (NCI) | 2006-01-01 |
| Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas (NCT00268385) | National Cancer Institute (NCI) | 2005-12-16 |
| Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00238303) | National Cancer Institute (NCI) | 2005-09-01 |
| Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors (NCT00110032) | National Cancer Institute (NCI) | 2005-06-01 |
| Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma (NCT00112736) | National Cancer Institute (NCI) | 2005-04-01 |
| Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00085254) | National Cancer Institute (NCI) | 2005-04-01 |
| FR901228 in Treating Patients With Recurrent High-Grade Gliomas (NCT00085540) | National Cancer Institute (NCI) | 2005-01-01 |
| Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme (NCT00112866) | National Cancer Institute (NCI) | 2005-01-01 |
| Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT00093613) | National Cancer Institute (NCI) | 2004-12-01 |
| Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme (NCT00075491) | National Cancer Institute (NCI) | 2003-12-01 |
| Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00058097) | National Cancer Institute (NCI) | 2003-08-01 |
| Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors (NCT00039494) | National Cancer Institute (NCI) | 2002-12-01 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas (NCT00045708) | National Cancer Institute (NCI) | 2002-10-01 |
| Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT00045565) | National Cancer Institute (NCI) | 2002-10-01 |
| Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02227901) | National Cancer Institute (NCI) | 2002-09-01 |
| Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110) | National Cancer Institute (NCI) | 2002-08-01 |
| Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme (NCT00052208) | National Cancer Institute (NCI) | 2002-03-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma (NCT00430079) | National Cancer Institute (NCI) | 2001-07-01 |
| CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00016328) | National Cancer Institute (NCI) | 2001-05-01 |
| Bortezomib in Treating Patients With Recurrent Glioma (NCT00006773) | National Cancer Institute (NCI) | 2001-05-01 |
| Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00014170) | National Cancer Institute (NCI) | 2001-03-01 |
| Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM (NCT00004146) | National Cancer Institute (NCI) | 2000-03-01 |
| Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme (NCT00004262) | National Cancer Institute (NCI) | 1999-11-01 |
| Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02055196) | City of Hope Medical Center | |